Marcus Schuchmann

6.4k total citations · 2 hit papers
110 papers, 4.9k citations indexed

About

Marcus Schuchmann is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Marcus Schuchmann has authored 110 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hepatology, 54 papers in Epidemiology and 29 papers in Molecular Biology. Recurrent topics in Marcus Schuchmann's work include Liver Disease Diagnosis and Treatment (32 papers), Hepatitis C virus research (25 papers) and Hepatitis B Virus Studies (23 papers). Marcus Schuchmann is often cited by papers focused on Liver Disease Diagnosis and Treatment (32 papers), Hepatitis C virus research (25 papers) and Hepatitis B Virus Studies (23 papers). Marcus Schuchmann collaborates with scholars based in Germany, United States and Switzerland. Marcus Schuchmann's co-authors include Peter R. Galle, Jörn M. Schattenberg, Gerd Otto, Arndt Weinmann, Henning Schulze‐Bergkamen, Maria Hoppe‐Lotichius, Ansgar W. Lohse, Michael Heise, David Wallach and Michael B. Pitton and has published in prestigious journals such as SHILAP Revista de lepidopterología, Immunity and The Journal of Immunology.

In The Last Decade

Marcus Schuchmann

108 papers receiving 4.8k citations

Hit Papers

Targeted Disruption of the Mouse Caspase 8 Gene Ablates C... 1998 2026 2007 2016 1998 2013 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus Schuchmann Germany 36 1.9k 1.8k 1.7k 1.3k 903 110 4.9k
Willscott E. Naugler United States 24 1.6k 0.9× 1.0k 0.6× 1.4k 0.8× 893 0.7× 774 0.9× 42 4.6k
Dianne H. Dapito United States 17 1.3k 0.7× 2.0k 1.1× 2.2k 1.3× 735 0.6× 769 0.9× 18 4.3k
Hitoshi Asakura Japan 41 1.4k 0.8× 1.4k 0.8× 1.7k 1.0× 1.7k 1.3× 907 1.0× 187 5.7k
Kazushi Sugimoto Japan 34 1.9k 1.0× 1.2k 0.7× 1.1k 0.6× 739 0.6× 415 0.5× 134 4.0k
Simon C. Afford United Kingdom 36 1.0k 0.6× 1.9k 1.1× 1.1k 0.7× 1.1k 0.9× 1.6k 1.8× 114 4.6k
Takahiro Kodama Japan 39 2.4k 1.3× 884 0.5× 1.3k 0.8× 1.3k 1.0× 848 0.9× 176 5.8k
Eishiro Mizukoshi Japan 40 1.2k 0.6× 2.2k 1.2× 2.0k 1.2× 1.7k 1.4× 529 0.6× 164 5.4k
Elke Roeb Germany 37 979 0.5× 1.2k 0.7× 1.6k 0.9× 571 0.5× 724 0.8× 154 4.3k
Tatsuya Kanto Japan 46 1.9k 1.0× 2.6k 1.5× 2.5k 1.5× 2.8k 2.2× 387 0.4× 218 6.9k
Hong Ren China 38 1.4k 0.7× 1.8k 1.0× 2.2k 1.3× 844 0.7× 305 0.3× 310 5.4k

Countries citing papers authored by Marcus Schuchmann

Since Specialization
Citations

This map shows the geographic impact of Marcus Schuchmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Schuchmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Schuchmann more than expected).

Fields of papers citing papers by Marcus Schuchmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Schuchmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Schuchmann. The network helps show where Marcus Schuchmann may publish in the future.

Co-authorship network of co-authors of Marcus Schuchmann

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Schuchmann. A scholar is included among the top collaborators of Marcus Schuchmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Schuchmann. Marcus Schuchmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuiper, J. W., Marcel Kremer, Ramon Kranaster, et al.. (2020). Detection of SARS-CoV-2 from raw patient samples by coupled high temperature reverse transcription and amplification. PLoS ONE. 15(11). e0241740–e0241740. 6 indexed citations
2.
Zwicker, Felix, et al.. (2018). Image of the month: Gastropericardial fistula. Clinical Medicine. 18(3). 261–262. 1 indexed citations
3.
Kabitz, Hans‐Joachim, et al.. (2016). Medication and Treatment Adherence Following Hospital Discharge. Deutsches Ärzteblatt international. 113(44). 749–756. 12 indexed citations
4.
Asselah, Tarik, Stefan Zeuzem, Vincent Soriano, et al.. (2015). ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection. PLoS ONE. 10(12). e0144004–e0144004. 4 indexed citations
6.
Zeuzem, Stefan, Vincent Soriano, Tarik Asselah, et al.. (2014). Efficacy and Safety of Faldaprevir, Deleobuvir, and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C Virus Infection and Advanced Liver Fibrosis or Cirrhosis. Antimicrobial Agents and Chemotherapy. 59(2). 1282–1291. 8 indexed citations
7.
Dieterich, Douglas T., Tarik Asselah, Dominique Guyader, et al.. (2014). SILEN-C3, a Phase 2 Randomized Trial with Faldaprevir plus Pegylated Interferon α-2a and Ribavirin in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients. Antimicrobial Agents and Chemotherapy. 58(6). 3429–3436. 9 indexed citations
8.
Zeuzem, Stefan, Tarik Asselah, Peter Angus, et al.. (2013). Faldaprevir (Bi 201335), Deleobuvir (Bi 207127) and Ribavirin Oral Therapy for Treatment-Naive HCV Genotype 1: Sound-C1 Final Results. Antiviral Therapy. 18(8). 1015–1019. 33 indexed citations
9.
Wörns, Marcus‐Alexander, Sandra Koch, M Nguyen-Tat, et al.. (2012). Clinicopathologic Features and Prognosis of Young Patients With Hepatocellular Carcinoma in a Large German Cohort. Journal of Clinical Gastroenterology. 46(9). 775–778. 13 indexed citations
10.
Pannicke, Nadine, Martina Sterneck, Christine zu Eulenburg, et al.. (2010). LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS : AN ANALYSIS OF MEDICAL AND SURGICAL RISK FACTORS. Transplant International. 23. 26–26. 2 indexed citations
11.
Weber, Achim, Regina Boger, Binje Vick, et al.. (2009). Hepatocyte‐specific deletion of the antiapoptotic protein myeloid cell leukemia‐1 triggers proliferation and hepatocarcinogenesis in mice†. Hepatology. 51(4). 1226–1236. 95 indexed citations
12.
Zimmermann, Tim, Gerd Otto, & Marcus Schuchmann. (2009). Managing hepatitis C in liver transplant patients with recurrent infection. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Vick, Binje, Achim Weber, Toni Urbanik, et al.. (2008). Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes #. Hepatology. 49(2). 627–636. 125 indexed citations
14.
Otto, Gerd, Marcus Schuchmann, J Thies, et al.. (2006). Das Interdisziplinäre Hepatologische Zentrum Mainz. Visceral Medicine. 22(4). 219–223. 1 indexed citations
15.
Xu, Jian, Rudolf Lucas, Marcus Schuchmann, et al.. (2003). GM-CSF Restores Innate, But Not Adaptive, Immune Responses in Glucocorticoid-Immunosuppressed Human Blood In Vitro. The Journal of Immunology. 171(2). 938–947. 22 indexed citations
16.
Schuchmann, Marcus & Peter R. Galle. (2003). Sensitizing to apoptosis—sharpening the medical sword. Journal of Hepatology. 40(2). 335–336. 19 indexed citations
17.
Varfolomeev, Eugene, Marcus Schuchmann, Victor Luria, et al.. (1998). Targeted Disruption of the Mouse Caspase 8 Gene Ablates Cell Death Induction by the TNF Receptors, Fas/Apo1, and DR3 and Is Lethal Prenatally. Immunity. 9(2). 267–276. 999 indexed citations breakdown →
18.
Hess, Sigrun, et al.. (1998). CD40 induces resistance to TNF-mediated apoptosis in a fibroblast cell line. European Journal of Immunology. 28(11). 3594–3604. 1 indexed citations
19.
Hess, Sigrun, et al.. (1998). CD40 induces resistance to TNF-mediated apoptosis in a fibroblast cell line. European Journal of Immunology. 28(11). 3594–3604. 35 indexed citations
20.
Schuchmann, Marcus, Sigrun Hess, Philip Bufler, et al.. (1995). Functional discrepancies between tumor necrosis factor and lymphotoxin α explained by trimer stability and distinct receptor interactions. European Journal of Immunology. 25(8). 2183–2189. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026